Overweight Clinical Trial
— SedestActivOfficial title:
Effectiveness of an Intervention to Reduce Diary Hours of Sitting Time in Overweight and Obese Patients (SEDESACTIV):Simple Randomized Controlled Trial
Primary care centres are a key setting to treat people with overweight and moderate obesity.
There is growing evidence that sitting for a long time is negatively associated with
people's health. Interventions with the aim of reducing daily time of sedentary activities
can be an effective strategy to increase daily energy expenditure. To improve the
effectiveness of programmes promoting physical activity in primary care we need some clear
action protocols that can be easily integrated in the daily routines of primary care
professionals.
Objective. The objective of the study is to evaluate the effectiveness of a six-moth primary
care intervention to reduce diary hours of sitting time in overweight and obese sedentary
patients, as well as to increase their weekly caloric spend.
Methods. The design of the study is a simple randomized controlled trial. Ten primary care
centers will be invited to participate and will be randomized into control (CG) and
intervention group (IG). Each professional will randomly invite to participate voluntarily
moderate obese or overweight patients (BMI: 25-34,9 kg/m2) of both sexes, aged between 25
and 65 years old, who are 6 or more than 6 hours daily sitting. A total of 400 subjects (200
individuals in each group) are needed. In addition, 50 subjects with fibromyalgia will be
included in the study to know the feasibility of the intervention among them.
The main dependent variable (sitting times) will be measured with an ActivPAL during first
and last intervention week. There will be a follow up after 3, 6 and 12 months of the end of
the intervention. Other variables included in the study: number of steps walked, subjective
level of physical activity, weight, height, BMI, skinfolds, waist circumference,
triglycerides, total cholesterol, (LDL and HDL), glucose, sociodemographic variables, blood
pressure and quality of life related to health. A descriptive analysis of all variables and
a multivariate analysis to assess differences among intervention and control group will be
undertaken. Multivariate analysis will be carried out to assess time changes of dependent
variables. All the analysis will be done under the intention to treat principle.
Status | Recruiting |
Enrollment | 450 |
Est. completion date | December 2016 |
Est. primary completion date | February 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 25 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Overweight and moderate obese patients (BMI: 25-34,9 kg/m2). - Be 6 or more than 6 hours daily sitting. - Able to walk and stand up from a chair unaided. - Subjects who can guarantee a year continuity in the study. Exclusion Criteria: - Recommended contradictions to advising physical activity to overweight and obese people. - Have an obesity surgical operation. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Spain | IDIAP Jordi Gol | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Jordi Gol i Gurina Foundation | Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Preventive Services and Health Promotion Research Network |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Skinfolds and waist circumference | Baseline-6-9-12 and 18 month | Yes | |
Other | Triglycerides, total cholesterol and glucose | Baseline-6-9-12 and 18 month | Yes | |
Primary | To assess the effectiveness of a 6-month primary care intervention to reduce diary hours of Sitting time in overweight and obese patients, as well as to increase their weekly caloric spend | In this part of the study will use two measure tools: 1) A sitting time test during a working day and during the weekends (Marshall Test). 2) The activPal device will measure the sitting, stand and walking minutes and Mets expended during a week period. | Baseline-6-9-12 and 18 month | Yes |
Secondary | Number of steps walked | Baseline-6-9-12 and 18 month | Yes | |
Secondary | Subjective level of physical activity | Baseline-6-9-12 and 18 month | Yes | |
Secondary | Quality of life related to health | Baseline-6-9-12 and 18 month | Yes | |
Secondary | Blood pressure | Baseline-6-9-12 and 18 month | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |